Redefining Medicine

Laura LaValle RDN, LD is the vice president of nutrition and dietetics for Metabolic Code Enterprises, an online wellness platform. She is a registered dietitian with over 20 years of experience in clinical dietetics in hospital settings and integrative nutrition private practice. Laura holds a B.S. in nutrition and has completed Level 2 Certificate of Training in Adult Weight Management through the American Academy of Nutrition and Dietetics. She is also a clinical instructor in the George Washington School of Health Sciences.

Today's episode of Redefining Medicine features Pamela Hyde, DO. Dr. Hyde has always had a deep passion for helping people realize their real power in taking control of their health and wellness. As a practitioner of Functional Medicine, Dr. Hyde and her team at AIM Wellness partner with clients to get to the root causes of chronic disease. Knowing 80% of all chronic disease is dictated by lifestyle and environment, she is dedicated to being a leader in changing the way we look at our health as well as recognizing the limits of our current healthcare system. ​

Dr. Hyde has been practicing Osteopathic Medicine for over 25 years. As a Board Certified Obstetrician and Gynecologist, she served for more than 17 years at Jackson County Memorial Hospital Women’s Health Associates in Altus, Oklahoma. Earning a Bachelor of Science in Nutrition Research from the University of Maryland, Dr. Hyde holds steadfast to the belief that food is medicine, prevention is the best approach. It makes the commitment to “walk her talk” every day.

In 2004 Dr. Hyde chose to further her postgraduate studies with The American Academy of Anti-Aging and Regenerative Medicine, going on to achieve the distinction of Board Certification and Advanced Fellow in 2009. As an expert in women’s health, hormones, and functional medicine, Dr. Hyde has been a keynote speaker at numerous symposiums and community events in the Southwest Oklahoma region. She serves as Medical Director for Life Services at Pathways, a pregnancy resource center located in Altus.

Today's episode of Redefining Medicine features Myles Spar, MD. Dr. Spar is a leading authority in Integrative Men’s Health as an author, teacher, researcher, TED talk speaker, contributor to Men’s Journal and the L.A. Times, expert on Dr. Oz and The Doctors TV shows and faculty member of UCLA, University of Arizona and Duke University Schools of Medicine.

Dr. Spar is board-certified in Internal Medicine, having graduated from the University of Michigan Medical School. He completed fellowships in Health Services Research at UCLA (where he earned a masters in public health) and in Integrative Medicine at the University of Arizona. Dr. Spar’s focus has always been about empowering men to achieve their goals through greater health. The men’s performance company where Dr. Spar oversees all clinical programs as Chief Medical Officer is called Vault Health. Vault brings men’s health to you, incorporating techniques to help men win at what matters to them.

Today's episode of Redefining Medicine features Michael Lustgarten, PhD. Dr. Michael Lustgarten is Scientist II on the Nutrition, Exercise Physiology, and Sarcopenia (NEPS) Team at the HNRCA. His research currently focuses on the role of the gut microbiome and serum metabolome on muscle mass and function in older adults. Dr. Lustgarten has been a guest lecturer at the Friedman School of Nutrition Science and Policy on topics such as the gut microbiome, serum metabolome, oxidative stress, exercise, and sarcopenia. He has contributed to 25 publications in leading peer-reviewed journals that have been cited more than 2,400 times, including 17 manuscripts as the first or last author.

Today's episode of Redefining Medicine features Robert Superko, MD. Dr. Superko’s research and clinical focus is on the metabolic and inherited aspects of coronary heart disease. He received his undergraduate degree from the University of California, San Diego, medical degree from the State University of New York-Stony Brook, and completed his internship, residency, and fellowship at the University of California, Davis. Over the past 35+ years he has completed multiple NIH trials including heart disease regression, coffee and lipoprotein metabolism, exercise and weight loss with a focus on lipoprotein subclass distribution, firefighter heart disease, and genetics. He served as Director of the Stanford University Lipid Research Clinic and Laboratory, the Director of the Cholesterol Research Center at the University of California-Berkeley, the Director of the American Heart Association Lipid Disorders Training Center, the Founder of Berkeley HeartLab, and Director of the Center for Human Genomics at the Saint Joseph’s Hospital/Mercer University in Atlanta, Georgia. His most recent investigation was the National Firefighter Heart Disease Prevention study which revealed metabolic and genetic contributors to the epidemic of coronary heart disease in firefighters. This work has now expanded to a National non-profit program that helps identify firefighters vulnerable to a sudden coronary event and works to prevent CHD events in this professional population that serves to protect the rest of us. Dr. Superko also served as the Chief Medical Officer of Celera corp. (human genome in 2001). He has published 166 manuscripts, authored 19 textbook chapters, and 130 invited presentations at National and International scientific meetings for a total of 320 publications. He is the recipient of many awards including the Larry King Physician Laurete award, the Montague Boyd Award for Best Research Article, and the Doc Hopkins award from the California American Heart Association for New Insights.

Today's episode of Redefining Medicine features Wade M. Cooper, DO. Dr. Cooper is the Director of Headache & Neuropathic Pain at the University of Michigan where he is also a Clinical Associate Professor in Neurology and Clinical Associate Professor in Anesthesiology. Dr. Cooper graduated from Michigan State University’s College of Osteopathic Medicine where he obtained his medical degree in 2000. He completed his residency in neurology at the Sparrow Hospital Health System in Michigan in 2004. He also completed a fellowship in neurology at the Michigan Head Pain & Neurological Institute in 2005. Dr. Cooper holds a United Council for Neurologic Subspecialties (UCNS) board certification in Headache Medicine. What drew Dr. Cooper into the field of headache medicine was the immense unmet need and lack of patient access to high quality care.

Today's episode of Redefining Medicine features Jeff Bost PA-C. Jeff is a Clinical Instructor in the Department of Neurosurgery at University of Pittsburgh Medical Center and Clinical Assistant Professor at Chatham University. He has a special interest in minimally invasive spine and brain surgery and have collaborated on scores of scientific medical papers and books in these areas. Over the last 15 years he has researched, lectured and written on the use of alternative treatment for pain control. Mr Bost, along with Dr Joseph Maroon have authored two books on the use of omega-3 fish oil, including: Fish Oil: The Natural Anti-Inflammatory, currently in its forth printing with over 75,000 copies sold and recently, Why You Need Fish Oil. He has given over 100 invited lectures, 24 national posters and oral presentations, 29 coordinated research projects, five workshops presentations, 35 scientific articles and 10 book chapters.

Today's episode of Redefining Medicine features Joseph Lamb, MD. Joseph J. Lamb, M.D. completed his graduate education at the Medical College of Virginia and his Internal Medicine residency at Presbyterian University of Pennsylvania Medical Center. He is board-certified in Internal Medicine and Holistic Medicine/Integrative Medicine. From 2015 to 2018, Dr. Lamb practiced at the Hypertension Institute in Nashville. Dr. Lamb has been the Medical Director for Nature's Sunshine Products since 2014. He opened the Personalized Lifestyle Medicine Center by Metagenics in October 2018. Dr. Lamb specializes in Internal and Functional Medicine with a special interest in cardio-metabolic disorders. He sees a broad range of health issues including autoimmune conditions, fibromyalgia, chronic Lyme disease, thyroid and other hormonal disorders. Dr. Lamb strongly believes that health is more than the simple absence of disease. His goal is to provide assistance as his patients journey through illness and disease to optimal wellness.

Today's episode of Redefining Medicine features Dr. Dale Bredesen. An internationally recognized expert in the mechanisms of neurodegenerative diseases, Dr. Dale Bredesen’s career has been guided by a simple idea: that Alzheimer’s as we know it is not just preventable, but reversible. Thanks to a dedicated pursuit of finding the science that makes this a reality, this idea has placed Dr. Bredesen at the vanguard of neurological research and led to the discoveries that today underlie the ReCODE Report.

Dr. Bredesen earned his MD from Duke University Medical Center and served as Chief Resident in Neurology at the University of California, San Francisco (UCSF), before joining Nobel laureate Stanley Prusiner’s laboratory at UCSF as an NIH Postdoctoral Fellow. He held faculty positions at UCSF, UCLA, and the University of California, San Diego. Dr. Bredesen also directed the Program on Aging at the Burnham Institute before joining the Buck Institute in 1998 as founding President and CEO.

Dr. Bredesen’s research explores previously uncharted territory in explaining the physical mechanism behind the erosion of memory seen in Alzheimer’s disease, and has opened the door to new approaches to treatment. This work has led to the identification of several new therapeutic processes that are showing remarkable early results. Dr. Bredesen is a prodigious innovator in medicine, with over thirty patents to his name. Notably, he put much of his findings and research into the 2017 New York Times‘ Best-Seller, The End of Alzheimer’s.

Today's episode of Redefining Medicine features Robyn S. Klein. Dr. Robyn S. Klein received her M.D. and Ph.D. degrees from Albert Einstein College of Medicine. She then completed her internship and residency in Internal Medicine at the Brigham & Women’s Hospital, her fellowship in Infectious Diseases at the Massachusetts General Hospital, and post-doctoral training in Immunology at Harvard University. Dr. Klein joined the Washington University School of Medicine (WUSM) in 2003, where she developed neuroimmunology basic and translational science research programs focused on the pathogenesis of neuroinflammatory diseases of the central nervous system (CNS). Studies in the Klein laboratory focus on cellular and molecular mechanisms that orchestrate inflammation and CNS dysfunction during both viral and autoimmune encephalitides. The experimental approach involves the development of in vitro and in vivo models of blood-brain barrier function to study the CNS entry of viruses and mononuclear cells, and of the signaling responses that regulate vascular permeability. Studies using in vivo models for both autoimmune and WNV encephalitides focus on identifying the localizing cues that control leukocyte entry, persistent inflammation and neuronal injury. Dr. Klein is currently the Associate Dean for Graduate Education in the Division of Biology & Biomedical Sciences and Director of the Center for Neuroimmunology & Neuroinfectious Diseases at WUSM and Vice Provost of Washington University in St. Louis, MO.